Related Experiment Videos
[Aspirin in primary prevention of ischemic heart disease]
Kardiologiia
|December 21, 2002
Insights
Aspirin is effective for secondary prevention after heart attack and stroke. For primary prevention, low-dose aspirin may benefit men at high risk for coronary heart disease but without major stroke risk factors.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Preventive Cardiology
Context:
- Aspirin's role in secondary prevention of cardiovascular events is well-documented.
- The utility of aspirin for primary prevention of coronary heart disease (CHD) and other cardiovascular diseases (CVD) is less clear.
- High-risk populations require nuanced approaches to preventive pharmacotherapy.
Purpose:
- To evaluate the efficacy and safety of aspirin in primary prevention of cardiovascular diseases.
- To identify specific subgroups of high-risk individuals who may benefit from aspirin therapy.
- To clarify the optimal use of aspirin in the context of varying risk profiles for stroke and coronary heart disease.
Summary:
- Analysis of large controlled trials suggests low-dose aspirin is beneficial for primary prevention in specific high-risk groups.
- Findings indicate that men with a high risk of coronary heart disease but lacking major stroke risk factors are suitable candidates for low-dose aspirin therapy.
- The study emphasizes a risk-stratified approach to aspirin use in primary cardiovascular prevention.
Impact:
- Provides evidence-based guidance for the primary prevention of cardiovascular disease with aspirin.
- Helps clinicians tailor aspirin prescriptions to individual patient risk profiles, optimizing benefits and minimizing potential harms.
- Contributes to the ongoing discussion on the role of aspirin in public health and preventive medicine.
Abstract:
High efficacy of aspirin in secondary prevention after myocardial infarction and stroke is well established. However the place of aspirin in primary prevention of coronary heart disease and other cardiovascular diseases remains questionable. Analysis of results of large controlled studies of efficacy and safety of aspirin in high risk subjects shows that low doses of aspirin should be used in men with high risk of coronary heart disease but without main risk factors of stroke.